Controlled release systems based on poly(lactic acid). An in vitro and in vivo study

A G Andreopoulos; E C Hatzi; M Doxastakis

doi:10.1023/a:1008990109419

Controlled release systems based on poly(lactic acid). An in vitro and in vivo study

J Mater Sci Mater Med. 2000 Jun;11(6):393-7. doi: 10.1023/a:1008990109419.

Authors

A G Andreopoulos¹, E C Hatzi, M Doxastakis

Affiliation

¹ Department of Chemical Engineering, National Technical University of Athens, 9 Iroon Polytechniou Str, 15780 Athens, Greece. andreo@orfeas.chemeng.ntua.gr

PMID: 15348021
DOI: 10.1023/a:1008990109419

Abstract

A new biodegradable delivery system based on poly(lactic acid) has been formulated, with potential applications in sustained antibiotic release against bone infection. The in vitro release of a new quinolone (pefloxacin) from low molecular weight poly(D,L-lactic acid) Mw = 2 x 10(3) lasted for 56 d whereas the in vivo delivery lasted 33 d. In both cases, the release rate is controlled by the drug diffusion and the polymer degradation, which seems to be the predominant factor. For the release experiments, discs were prepared from poly (D,L-lactide) Mw = 2 x 10(4) with drug loadings of 2% and 10% w/w. It was concluded that pefloxacin concentration remains higher than the Minimum Inhibitory Concentration (MIC) against the major causative bacteria of bone infection. The results indicate that the two different types of poly(lactic acid) can be used effectively in an implantable antibiotic release system.